ReviewJournal of neurology2026

A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease.

Mohamed M Hafez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.